Ablynx NV has received a €2.1 million grant from a government body in the Flanders region of Belgium to investigate the treatment of eye diseases with the company’s antibody-derived therapeutics which go by the name of Nanobodies. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
